How Innovation is Transforming the US Mucopolysaccharidosis Treatment Market in 2026–2034
The United States represents the largest share of the Mucopolysaccharidosis Treatment Market, driven by its advanced healthcare infrastructure, strong presence of leading biopharmaceutical companies, and favorable regulatory support for orphan drugs. The country has established comprehensive newborn screening programs and rare disease awareness initiatives that enable early diagnosis and...
0 Commentarios 0 Acciones 7 Views 0 Vista previa